Caffeine reduces TNFα up-regulation in human adipose tissue primary culture

Journal of Physiology and Biochemistry

Volumn 63, Issue 4, 2007, Pages 329-336

  Dray, C ^a,b   Daviaud, D ^a,b   Guigne C ^a,b   Valet, P ^a,b   Castan Laurell, I ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Adipocytes; Gene expression; IL 6; Primary culture; Stroma Vascular Fraction; TNF

Indexed keywords

CAFFEINE; COLLAGENASE; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EXPLANT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIPECTOMY; OBESITY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; TISSUE CULTURE; UPREGULATION; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; SUBCUTANEOUS FAT;

ADIPOCYTES; BODY MASS INDEX; CAFFEINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; RNA, MESSENGER; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 41849089392     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03165764     Document Type: Article

References (25)

1. Bastard, J.P., Maachi, M., Van Nhieu, J.T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.J., Capeau, J. and Hainque, B. (2002): J. Clin. Endocrinol. Metab, 87, 2084-2089.
2. Coppack, S.W. (2001): Proc. Nutr. Soc., 60, 349-56.
3. Dandona, P., Aljada, A. and Bandyopadhyay, A. (2004): Trends Immunol., 25, 4-7.
4. Dandona, P., Weinstock, R., Thusu, K., Abdel-Rahman, E., Aljada, A. and Wadden, T. (1998) J. Clin. Endocrinol. Metab., 83, 2907-2910.
5. Feve, B., Bastard, J.P. and Vidal, H. (2006): C. R. Biol., 329, 587-597; 653-655.
6. Gesta, S., Lolmede, K., Daviaud, D., Berlan, M., Bouloumié, A., Lafontan, M., Valet, P. and Saulnier-Blache, J.S. (2003): Horm. Metab. Res., 35, 158-163.
7. Ghezzi, P., Dinarello, C.A., Bianchi, M., Rosandich, M.E., Repine, J.F. and White, C.W. (1991): Cytokine, 3, 189-194.
8. Greenberg, A.S. and Obin, M.S. (2006): Am. J. Clin. Nutr., 83, 461S-465S.
9. Horrigan, L.A., Kelly, J.P. and Connor, T.J. (2004): Int. Immunopharmacol., 4, 1409-1417.
10. Hotamisligil, G.S., Murray, D.L., Choy, L.N. and Spiegelman, B.M. (1994): Proc. Natl. Acad. Sci. U S A, 91, 4854-4858.
11. Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M. (1993): Science, 259, 87-91.
12. Hotamisligil, G.S. and Spiegelman, B.M. (1994): Diabetes, 43, 1271-1278.
13. Hube, F., Lee, Y.M., Rohrig, K. and Hauner, H. (1999): Horm. Metab. Res., 31, 359-362.
14. Kern, P.A., Ranganathan, S., Li, C., Wood, L. and Ranganathan, G. (2001): Am. J. Physiol. Endocrinol. Metab., 280, E745-751.
15. Kern, P.A., Saghizadeh, M., Ong, J.M., Bosch, R.J., Deem, R. and Simsolo, R.B. (1995): J. Clin. Invest., 95, 2111-2119.
16. Lelo, A., Miners, J.O., Robson, R. and Birkett, D.J. (1986): Clin. Pharmacol. Ther., 39, 54-59.
17. Lim, Y.C., Gough, M.J., Homer-Vanniasinkam, S. and Parkin, S.M. (1997): Biochem. Soc. Trans., 25, 231S.
18. Ofei, F., Hurel, S., Newkirk, J., Sopwith, M. and Taylor, R. (1996): Diabetes, 45, 881-885.
19. Qi, C. and Pekala, P.H. (2000): Proc. Soc. Exp. Biol. Med., 223, 128-315.
20. Scannell, G., Waxman, K., Kaml, G.J., Ioli, G., Gatanaga, T., Yamamoto, R. and Granger, G.A. (1993): J. Surg. Res., 54, 281-285.
21. Schreyer, S.A., Chua, S.C., Jr. and LeBoeuf, R.C. (1998): J. Clin. Invest., 102, 402-411.
22. Semmler, J., Gebert, U., Eisenhut, T., Moeller, J., Schonharting, M.M., Allera, A. and Endres, S. (1993): Immunology, 78, 520-525.
23. Sethi, J.K. and Hotamisligil, G.S. (1999): Semin. Cell. Dev. Biol., 10, 19-29.
24. Taylor, C.T., Fueki, N., Agah, A., Hershberg, R.M. and Colgan, S.P. (1999): J. Biol. Chem., 274, 19447-19454.
25. Trujillo, M.E. and Scherer, P.E. (2006): Endocr. Rev., 27, 762-778.